
ABSCF News Today: Stay Updated with the Latest AB Science S.A. News in Real Time
Find ABSCF news now at Meyka AI. Stay informed with the latest AB Science S.A. stocks updates, including price news, market analysis, and expert insights.

Xi’s North Korea Visit Signals Shift on Nuclear Weapons, June 10
Xi Jinping visits North Korea for first time in seven years, avoiding nuclear talks and signaling China’s acceptance of Pyongyang’s weapons arsenal.

UPSC Prelims 2026 Result Expected This Week, 5.49 Lakh Await Verdict
UPSC Prelims 2026 result expected in June. 5.49 lakh candidates compete for 933 IAS, IPS, IFS vacancies. Check upsc.gov.in.

Trump’s Proposed $100,000 H-1B Visa Fee Struck Down; What It Means for Indian Professionals
A major development in U.S. immigration policy has brought relief to thousands of skilled foreign workers and employers. A federal judge has struck down former President Donald Trump’s proposed $100,000 H-1B Visa fee, ruling that the administration lacked the legal authority to impose such a charge without approval from Congress. The ruling came from U.S….

Tate & Lyle (LON: TATE) Agrees £2.7 Billion Takeover by Ingredion (NYSE: INGR) at 615p Per Share Deal
The global food ingredients industry is witnessing a major shake-up. UK-based Tate & Lyle has agreed to a £2.7 billion takeover deal by US rival Ingredion. The deal values Tate & Lyle at 615 pence per share, including cash and dividends. This marks one of the biggest cross-border food sector deals in recent years. We…

DRDO SAG Internship 2026: 40 Positions Open for Engineering Students
DRDO SAG internship 2026: 40 positions for B.Tech and M.Sc students. Six-month program from July 1, 2026. Rs 30,000 monthly stipend.

Ancient Yeast Bakes 5,300-Year-Old Sourdough, June 05
Scientists extract yeast from 5,300-year-old mummy Ötzi and successfully bake sourdough bread using ancient fungi. Researchers plan to brew beer next.

Eli Lilly Retevmo Cuts Cancer Recurrence or Death Risk by 83% in Phase 3 Trial of 151 NSCLC Patients
On May 31, 2026, Eli Lilly (NYSE: LLY) delivered one of the most significant oncology data readouts of the year. The Phase 3 LIBRETTO-432 trial of Retevmo (selpercatinib) met its primary endpoint with results that are difficult to overstate. In 151 patients with early-stage RET fusion-positive non-small cell lung cancer (NSCLC), Retevmo reduced the risk…

India Launches ‘Save Our Fields’ Campaign on June 1 to Cut Farm Costs
India’s Khet Bachao Abhiyan campaign launches June 1 to reduce farm costs, improve soil health, and promote sustainable agriculture nationwide.

Shenzhou 21 Crew Returns After 210-Day Space Station Record, May 30
Shenzhou 21 astronauts safely return after 210-day record mission with 41kg of space station research samples from 23 projects.